MICHR to tackle goal of diversifying and improving research to speed therapies for benefit of all patients
A new groundbreaking study from the University of Michigan’s Center for Drug Repurposing (CDR) reveals several drug contenders already in use for other purposes—including one dietary supplement—that have been shown to block or reduce SARS-CoV-2 infection in cells.
The study, published recently in the Proceedings of the National Academy of Sciences, uses artificial intelligence-powered image analysis of human cell lines during infection with the novel coronavirus.
Are you interested in positioning your interdisciplinary research team to be competitive for an external large-scale grant (e.g., NIH U- and P-series mechanisms)? If so, you’re encouraged to apply for $100,000 in funding and tailored research support available through the Accelerating Synergy Award.
In an effort to make access to experimental agents easier and more efficient, Transforming Expanded Access to Maximize Support and Study (TEAMSS) has published new recommended guidelines, templates, and resources for physicians and institutions seeking Expanded Access for their patients.
Volunteering in community programs with older adults in North Minneapolis, studying geography and gerontology, and experiencing the devastating effects of dementia in her own family drove Jessica Finlay, PhD toward novel public health research on environmental factors affecting dementia risk.
Kozik designed the logo on her KoziMicrobe website, where she introduces herself as a U-M microbiologist and research investigator. She co-founded the Black Microbiologists Association and is interested in the human microbiome, systems biology, and inflammatory disease.
